Building New Cell Therapy Workflow Solutions with Closed Automated Technology

The autologous cell and gene therapy workflow involves isolating cells from an individual, engineering the cells, expanding and concentrating them, and infusing them back into the patient. While processing and manufacturing of cell and gene therapy products is of vital importance to patients and has shown significant promise in the treatment of a wide range of diseases, it has still presented numerous challenges. Optimized automation of certain steps of the workflow using a closed cell processing system can decrease hands-on time and cost of the cell manufacturing process, as the same equipment can be utilized from research through commercial manufacturing, simplifying the process of therapeutic development.

Download this poster to discover a closed system solution that:

• Enables gentle cell isolation, and wash & concentrate
• Can work with a variety of cell types (including T cells, NK cells, PBMCs and more)
• Can be easily automated to serve many additional workflows